Companies House 07807964 2025-03-31 2025-03-31 2024-04-01 false iso4217:GBP xbrli:pure 07807964 2023-04-01 2024-03-31 07807964 2025-03-31 07807964 2024-04-01 2025-03-31 07807964 2024-03-31 07807964 curr:PoundSterling 2024-04-01 2025-03-31 07807964 uk-bus:CompanyLimitedByGuarantee 2024-04-01 2025-03-31 07807964 uk-bus:FRS102 2024-04-01 2025-03-31 07807964 uk-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 07807964 uk-bus:FullAccounts 2024-04-01 2025-03-31 07807964 uk-bus:RegisteredOffice 2024-04-01 2025-03-31 07807964 uk-bus:Director1 2024-04-01 2025-03-31 07807964 uk-bus:Director2 2024-04-01 2025-03-31 07807964 uk-bus:Director3 2024-04-01 2025-03-31 07807964 uk-bus:Director4 2024-04-01 2025-03-31 07807964 uk-bus:Director5 2024-04-01 2025-03-31 07807964 uk-bus:Director6 2024-04-01 2025-03-31 07807964 uk-bus:Director7 2024-04-01 2025-03-31 07807964 uk-bus:Director8 2024-04-01 2025-03-31 07807964 uk-bus:Director9 2024-04-01 2025-03-31 07807964 uk-bus:Director10 2024-04-01 2025-03-31 07807964 uk-bus:Director11 2024-04-01 2025-03-31 07807964 uk-bus:Director12 2024-04-01 2025-03-31 07807964 uk-bus:Director13 2024-04-01 2025-03-31 07807964 uk-bus:Director14 2024-04-01 2025-03-31 07807964 uk-bus:Director15 2024-04-01 2025-03-31 07807964 uk-bus:Director16 2024-04-01 2025-03-31 07807964 uk-bus:Director17 2024-04-01 2025-03-31 07807964 uk-bus:Director18 2024-04-01 2025-03-31 07807964 uk-bus:Director19 2024-04-01 2025-03-31 07807964 uk-bus:Director20 2024-04-01 2025-03-31 07807964 uk-bus:Director21 2024-04-01 2025-03-31 07807964 uk-bus:CompanySecretary1 2024-04-01 2025-03-31 07807964 core:AfterOneYear 2025-03-31 07807964 core:AfterOneYear 2024-03-31 07807964 core:WithinOneYear 2025-03-31 07807964 core:WithinOneYear 2024-03-31 07807964 core:WithinOneYear 2024-04-01 2025-03-31 07807964 core:AfterOneYear 2025-03-31 07807964 core:AfterOneYear 2024-03-31 07807964 core:AfterOneYear 2024-04-01 2025-03-31 07807964 core:ShareCapital 2025-03-31 07807964 core:ShareCapital 2024-03-31 07807964 core:SharePremium 2025-03-31 07807964 core:SharePremium 2024-03-31 07807964 core:OtherReservesSubtotal 2025-03-31 07807964 core:OtherReservesSubtotal 2024-03-31 07807964 core:RevaluationReserve 2025-03-31 07807964 core:RevaluationReserve 2024-03-31 07807964 core:RetainedEarningsAccumulatedLosses 2025-03-31 07807964 core:RetainedEarningsAccumulatedLosses 2024-03-31 07807964 1 2024-04-01 2025-03-31 07807964 2 2024-04-01 2025-03-31 07807964 3 2024-04-01 2025-03-31 07807964 core:LandBuildings 2024-04-01 2025-03-31 07807964 core:LandBuildings 2025-03-31 07807964 core:LandBuildings 2023-04-01 2024-03-31 07807964 core:LandBuildings 2024-03-31 07807964 core:PlantMachinery 2024-04-01 2025-03-31 07807964 core:PlantMachinery 2025-03-31 07807964 core:PlantMachinery 2023-04-01 2024-03-31 07807964 core:PlantMachinery 2024-03-31 07807964 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 07807964 core:FurnitureFittingsToolsEquipment 2025-03-31 07807964 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 07807964 core:FurnitureFittingsToolsEquipment 2024-03-31 07807964 core:OfficeEquipment 2024-04-01 2025-03-31 07807964 core:OfficeEquipment 2025-03-31 07807964 core:OfficeEquipment 2023-04-01 2024-03-31 07807964 core:OfficeEquipment 2024-03-31 07807964 core:Vehicles 2024-04-01 2025-03-31 07807964 core:Vehicles 2025-03-31 07807964 core:Vehicles 2023-04-01 2024-03-31 07807964 core:Vehicles 2024-03-31 07807964 core:NetGoodwill 2024-04-01 2025-03-31 07807964 core:NetGoodwill 2025-03-31 07807964 core:NetGoodwill 2023-04-01 2024-03-31 07807964 core:NetGoodwill 2024-03-31 07807964 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 07807964 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 07807964 core:IntangibleAssetsOtherThanGoodwill 2023-04-01 2024-03-31 07807964 core:IntangibleAssetsOtherThanGoodwill 2024-03-31

# SOUTH DURHAM HEALTH C.I.C.

## Company limited by guarantee

## Company Registration Number:
07807964 (England and Wales)

## Unaudited statutory accounts for the year ended 31 March 2025

## Period of accounts

## Start date: 1 April 2024

## End date: 31 March 2025

# SOUTH DURHAM HEALTH C.I.C.

## Contents of the Financial Statements

for the Period Ended 31 March 2025

Directors report |
Profit and loss |
Balance sheet |
Additional notes |
Balance sheet notes |
Community Interest Report |

# SOUTH DURHAM HEALTH C.I.C.

Directors' report period ended 31 March 2025

The directors present their report with the financial statements of the company for the period ended 31 March 2025

Principal activities of the company

The principal activity of the company continued to be that of a not for profit GP federation.

Additional information

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations. Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the surplus or deficit of the company for that period. In preparing these financial statements, the directors are required to: 1. select suitable accounting policies and then apply them consistently; 2. make judgements and accounting estimates that are reasonable and prudent; and 3. prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Directors

The directors shown below have held office during the whole of the period from
1 April 2024 to 31 March 2025

Dr N Sahoo
Dr KS Sidhu
Dr R Mansingh
Dr S Moss
Dr M Shield

The director shown below has held office during the period of
15 October 2024 to 31 March 2025

Dr C Morgan

Secretary Mrs Susan Watson

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
30 September 2025

And signed on behalf of the board by:
Name: Dr KS Sidhu
Status: Director

# SOUTH DURHAM HEALTH C.I.C.

## Profit And Loss Account

for the Period Ended 31 March 2025

| 2025 | 2024
--- | --- | ---
| £ | £
Turnover: | 4,227,628 | 4,021,903
Cost of sales: | ( 3,657,954 ) | ( 3,520,509 )
Gross profit(or loss): | 569,674 | 501,394
Administrative expenses: | ( 578,939 ) | ( 506,730 )
Operating profit(or loss): | (9,265) | (5,336)
Interest receivable and similar income: | 12,349 | 5,692
Profit(or loss) before tax: | 3,084 | 356
Tax: | ( 495 ) | 645
Profit(or loss) for the financial year: | 2,589 | 1,001

# SOUTH DURHAM HEALTH C.I.C.

## Balance sheet

As at 31 March 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Fixed assets
Tangible assets: | 3 | 8,580 | 10,095
Investments: | 4 | 100 | 100
Total fixed assets: |  | 8,680 | 10,195
Current assets
Debtors: | 5 | 1,235,897 | 758,044
Cash at bank and in hand: |  | 2,922,040 | 3,415,411
Total current assets: |  | 4,157,937 | 4,173,455
Creditors: amounts falling due within one year: | 6 | ( 3,820,894 ) | ( 3,840,137 )
Net current assets (liabilities): |  | 337,043 | 333,318
Total assets less current liabilities: |  | 345,723 | 343,513
Provision for liabilities: |  | ( 1,539 ) | ( 1,918 )
Total net assets (liabilities): |  | 344,184 | 341,595
Members' funds
Profit and loss account: |  | 344,184 | 341,595
Total members' funds: |  | 344,184 | 341,595

The notes form part of these financial statements

# SOUTH DURHAM HEALTH C.I.C.

## Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 30 September 2025
and signed on behalf of the board by:

Name: Dr KS Sidhu
Status: Director

The notes form part of these financial statements

# SOUTH DURHAM HEALTH C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 March 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Turnover policy

  Income and expenses are included in the financial statements as they become receivable or due.

  Tangible fixed assets depreciation policy

  Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases: Fixtures, fittings & equipment - 15% reducing balance Computer equipment - 15% reducing balance The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to surplus or deficit.

  Other accounting policies

  Accounting convention The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £. The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below. The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group. Fixed asset investments Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in surplus or deficit. A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities. Impairment of fixed assets At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Cash at bank and in hand Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks. Financial instruments The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. Taxation The tax expense represents the sum of the tax currently payable and deferred tax. Current tax The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date. Deferred tax Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit. Retirement benefits Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due. Past and present employees are covered by the provisions of the NHS Pensions Scheme. The scheme is an unfunded, defined benefit scheme that covers NHS employers, GP practices and other bodies, allowed under the direction of the Secretary of State, in England and Wales. The scheme is not designed to be run in a way that would enable NHS bodies to identify their share of the underlying scheme assets and liabilities. Therefore, the scheme is accounted for as if it were a defined contribution scheme: the cost to the NHS Body of participating in the scheme is taken as equal to the contributions payable to the scheme for the accounting period.

# SOUTH DURHAM HEALTH C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 March 2025

- ## 2. Employees

  | 2025 | 2024
  --- | --- | ---
  Average number of employees during the period | 12 | 11

# SOUTH DURHAM HEALTH C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 March 2025

## 3. Tangible assets

| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total
--- | --- | --- | --- | --- | --- | ---
Cost | £ | £ | £ | £ | £ | £
At 1 April 2024 |  |  | 3,209 | 20,775 |  | 23,984
Additions |  |  |  |  |  |
Disposals |  |  |  |  |  |
Revaluations |  |  |  |  |  |
Transfers |  |  |  |  |  |
At 31 March 2025 |  |  | 3,209 | 20,775 |  | 23,984
Depreciation |  |  |  |  |  |
At 1 April 2024 |  |  | 2,241 | 11,648 |  | 13,889
Charge for year |  |  | 146 | 1,369 |  | 1,515
On disposals |  |  |  |  |  |
Other adjustments |  |  |  |  |  |
At 31 March 2025 |  |  | 2,387 | 13,017 |  | 15,404
Net book value |  |  |  |  |  |
At 31 March 2025 |  |  | 822 | 7,758 |  | 8,580
At 31 March 2024 |  |  | 968 | 9,127 |  | 10,095

# SOUTH DURHAM HEALTH C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 March 2025

## 4. Fixed assets investments note

Shares in group undertakings and participating interests - £100 (2024: £100)

# SOUTH DURHAM HEALTH C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 March 2025

## 5. Debtors

| 2025 | 2024
--- | --- | ---
| £ | £
Trade debtors | 1,223,902 | 723,017
Prepayments and accrued income | 11,995 | 35,027
Total | 1,235,897 | 758,044

# SOUTH DURHAM HEALTH C.I.C.

## Notes to the Financial Statements

for the Period Ended 31 March 2025

## 6. Creditors: amounts falling due within one year note

| 2025 | 2024
--- | --- | ---
| £ | £
Trade creditors | 481,568 | 74,688
Taxation and social security | 874 | 406
Accruals and deferred income | 3,338,352 | 3,764,943
Other creditors | 100 | 100
Total | 3,820,894 | 3,840,137

# COMMUNITY INTEREST ANNUAL REPORT

### SOUTH DURHAM HEALTH C.I.C.

### Company Number: 07807964 (England and Wales)

### Year Ending: 31 March 2025

Company activities and impact

South Durham Health (SDH) is a federated group of General Practitioner (GP) practices and serves the localities of Easington, Sedgefield and surrounding areas in County Durham. The membership of SDH is drawn from partner General Practitioners in seventeen practices with a combined patient list size of over 180,000. The purpose of South Durham Health CIC is: To relieve Illness and promote health in South Durham, and: To ensure that General Practice in South Durham is viable because general practice is the best way of delivering the personalised, comprehensive health care which is essential to the health and well-being of people in South Durham. Our activities have principally benefited the community by providing additional, local and highly accessible services commissioned by NHS North East and North Cumbria and the Public Health Service of Durham County Council. SDH delivered contracts with a value of £3,605,700. The Vulnerable Adults Wrap Around Service consists of a team of highly experienced Advanced Nurse Practitioners (ANPs) who support the most vulnerable and elderly patients. They work closely with care home staff and other multi-disciplinary health care staff ensuring those they care for offered the care they need. The service offered covers 35 care homes and supports 1500 elderly care beds. Specialist mental health nurses provide accessible and timely appointments for adult patients referred by their GP practice. In 2024-25, through a combination of telephone and face-to-face consultations over 1000 appointments were offered. Our Primary Care Service helped people who required an urgent same day appointment with an ANP/ GP outside core practice hours and in 2024-25 over 22,000 appointment slots were made available. We contract with a number of practices to offer vital monitoring of anticoagulation therapy to patients in a local, familiar and accessible setting avoiding the need for a trip to a hospital. In 2024-25 we had over 4000 contacts with 467 of these visits delivered in the patients’ home. Our practices improved the care level offered to diabetes patients, initiating insulin treatment which may previously have required a hospital visit. All our practices are working with specialist nurses and hospital consultants to provide specialist care locally rather than through a hospital appointment with all participating delivering the Care ++ standards expected. In the winter of 2024-25 we again offered an acute respiratory hub to support the high demand in the community. Over 3200 appointments were offered during the 4 month winter period. We also introduced a new service for proactive COPD management in the light of emerging national guidance with nearly 1300 appointments offered. We use funds we generate through our activities to support practices to deliver additional services to patients or to provide improvements in the patient experience. During this year we invited practices to invest in new equipment, patient services, upgrades to their buildings or staff development against criteria linked to our aims and objectives. We provided assistance with additional training and development for practice staff via online training programmes and locality meetings. In 2024-25 we offered specific support to one member practice resulting in SDH running the practice for 9 months while the GP partner took an unplanned break in service. SDH is the managing agent for five local Primary Care Networks of GP practices and has supported their planning, finance and management functions throughout the year. We supported the recruitment process for First Contact Physiotherapists, Pharmacy Technicians, Trainee Nursing Associates, Social Prescribing Link Workers, Care Co-ordinators and Physicians Associates as well as overseeing and supporting the national performance management requirements for PCNs. In 2024-25, SDH supported all 5 PCNs with the implementation of its Integrated Neighbourhood Team programmes.

Consultation with stakeholders

Stakeholders include the populations of Easington, Sedgefield and surrounding areas; members within GP practices and their staff; Primary Care Networks; NHS organisations locally and organisations involved in the delivery of health and social care; local authorities; voluntary organisations supporting the communities served by SDH; groups representing patients. There has been no formal consultation on our activities this year. SDH seeks the views of its members, providing feedback on its work via an Annual Report and Annual General Meeting and encouraging discussion to inform the agendas for future years. We are in regular contact with staff in all practices and seek their views and feedback on our activities. We agree with Clinical Directors of Primary Care Networks what services they require from us to achieve their requirements and seek to match our staffing numbers and skill-mix to respond to their needs. We are transparent about our activities and our Annual Report and updates on our services are available to any interested party via our web site. Feedback from patients is collected on services provided by South Durham and used to inform the development of services. This is done by means of service specific questionnaires and through use of the Friends and Family test for the Primary Care Service and Primary Mental Health service.

Directors' remuneration

Dr N Sahoo (£2,701), Dr KS Sidhu (£15,436), Dr R Mansingh (£2,251), Dr S Moss (£3,151), Dr C Morgan (£1,350), Dr M Shield (£2,251)

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
30 September 2025

And signed on behalf of the board by:
Name: Susan Watson
Status: Director